norfloxacin and 1,10-phenanthroline

norfloxacin has been researched along with 1,10-phenanthroline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohnert, JA; Karamian, B; Nikaido, H1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Baptista, T; de Castro, B; Gameiro, P; Rodrigues, C; Sousa, I1
Efthimiadou, EK; Karaliota, A; Katsarou, ME; Psomas, G; Vourloumis, D1

Other Studies

4 other study(ies) available for norfloxacin and 1,10-phenanthroline

ArticleYear
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Solution studies on binary and ternary complexes of copper(II) with some fluoroquinolones and 1,10-phenanthroline: Antimicrobial activity of ternary metalloantibiotics.
    International journal of pharmaceutics, 2007, Apr-04, Volume: 334, Issue:1-2

    Topics: Anti-Bacterial Agents; Copper; Drug Design; Drug Resistance, Microbial; Drug Stability; Ligands; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Phenanthrolines; Potentiometry; Spectrophotometry, Ultraviolet

2007
Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
    Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Copper; Deoxyribonucleases; DNA, Superhelical; Escherichia coli; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Necrosis; Norfloxacin; Organometallic Compounds; Phenanthrolines; Pseudomonas aeruginosa; Staphylococcus aureus

2008